查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1808628

呼吸診斷市場（按診斷測試、患者人口統計、產品和最終用戶）—2025-2030 年全球預測

Respiratory Diagnostics Market by Diagnostic Tests, Patient Demographics, Offerings, End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計呼吸診斷市場規模到 2024 年將達到 66.6 億美元，到 2025 年將達到 72.6 億美元，到 2030 年將達到 109.7 億美元，複合年成長率為 8.66%。

主要市場統計數據
基準年2024年 66.6億美元
預計2025年 72.6億美元
預測年份 2030 109.7億美元
複合年成長率（%） 8.66%

利用新技術和監管趨勢引領複雜的呼吸診斷環境，引領未來發展

在技​​術創新和全球健康緊迫性的雙重推動下，呼吸診斷市場正經歷前所未有的成長。隨著慢性呼吸系統疾病盛行率的上升和患者意識的增強，該行業已進入一個充滿活力的變革階段。先進的分析工具、照護現場設備和數位健康平台正在融合，以創造更準確、更快速、更方便的診斷途徑。此外，關鍵市場不斷變化的監管要求也帶來了新的合規挑戰，需要在整個價值鏈中製定適應性策略。

探索後疫情時代塑造呼吸診斷生態系統的關鍵技術與業務轉型

近年來，數位健康與人工智慧融合的突破性進展，徹底改變了呼吸診斷領域。機器學習演算法如今支援高解析度影像解讀，使臨床醫生能夠更準確地發現早期異常。同時，雲端基礎的分析平台能夠跨多個接觸點無縫聚合患者數據，從而更全面地洞察病情進展。這種轉變不僅縮短了診斷時間，也降低了整體營運成本。

2025年美國關稅實施對供應鏈、成本結構和市場適應性的綜合影響分析

2025年美國關稅調整對全球呼吸診斷供應鏈產生了重大影響。進口零件面臨關稅上調，迫使設備製造商重新評估籌資策略和合作夥伴網路。結果，製造成本大幅上升，尤其是高精度診斷成像系統和先進的分子檢測套件。為此，幾家主要製造商推行近岸外包，將組裝遷至更靠近終端市場的地方，以減輕關稅的影響並確保交付的連續性。

各種市場細分觀點，重點在於測試模式、人口統計、解決方案產品和最終用戶應用

仔細觀察診斷測試方式就會發現，動脈血氣分析和全血球計數等血液評估仍然是評估呼吸功能和識別全身性發炎的基本工具。胸部 X 光、 電腦斷層掃描和 MRI 掃描等診斷影像平台仍然是可視化結構異常的重要工具。同時，肺功能測試（例如肺量計、彌散能力測量和肺活量評估）對於追蹤疾病進展和指導治療性介入介入至關重要。先進的分子測試（例如 PCR 檢測、抗原檢測和生物標記分析）進一步提高了診斷準確性，而脈搏血氧計和痰液分析方案則有助於在臨床和家庭環境中進行持續監測。

分析美洲、歐洲、中東和非洲以及亞太地區呼吸診斷領域的區域成長動力和市場趨勢

呼吸診斷的區域動態因醫療基礎設施的成熟度、法規環境和經濟因素而明顯不同。在美洲，先進的臨床網路和廣泛的報銷體係正在推動高階成像系統和分子診斷的快速普及，而研究資金和公共衛生計劃則進一步推動了市場發展勢頭。歐洲、中東和非洲地區呈現出多元化的環境，西歐市場專注於技術成熟度和嚴格的監管合規性，而中東和北非地區國家則透過官民合作關係和有針對性的疾病篩檢計畫來提昇能力。

揭示影響呼吸診斷領域發展的主要企業的競爭動態和創新策略

呼吸診斷領域的主要企業正專注於多項關鍵策略，以保持競爭優勢。診斷影像系統製造商和軟體分析供應商之間正在形成策略聯盟，將硬體創新與先進的數據解讀演算法相結合。這種協作方式正在加速整合診斷平台的部署，從而實現無縫資料交換和遠端存取。同時，大型診斷集團對利基分子檢測開發商的收購正在增強其檢測產品組合，並擴大疾病檢測和個人化治療計劃的範圍。

提供富有洞察力的策略指南，以增強呼吸診斷產業的創新、協作和營運彈性

為了抓住市場機遇，產業領導者應優先投資可互通的數位平台，這些平台能夠整合各種診斷資料流，並支援即時決策。與軟體開發商和學術機構建立協作生態系統，使企業能夠共同打造先進的分析解決方案，從而始終領先於不斷變化的臨床需求。同時，透過雙重採購和近岸外包實現供應鏈多元化，可以緩解關稅相關的中斷，並確保設備供應的持續穩定。

闡明一個嚴格的多階段研究框架，整合初步檢驗和次要分析，以獲得可靠的呼吸診斷情報

本研究採用全面的多階段方法，以確保最高的準確性和可靠性。原始資料收集包括與關鍵意見領袖（包括肺科醫生、實驗室主任和監管專家）進行全面訪談，以獲得關於新興趨勢、臨床工作流程和採購促進因素的第一手見解。這些定性研究結果與已發表文獻、技術白皮書和監管資料庫的深入審查相輔相成，從而提供了堅實的二手資料基礎。

綜合關鍵發現與未來發展軌跡，指導呼吸診斷業務的策略發展與產業前景

綜上所述，本摘要概述的關鍵洞察表明，呼吸診斷領域正在進入一個由數位整合、策略供應鏈重組和協作創新定義的時代。先進成像平台與分子檢測之間的相互作用，正在推動人們對呼吸系統疾病的更深入理解。同時，監理改革和關稅政策凸顯了營運敏捷性和積極主動的相關人員參與的重要性。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章市場動態

  • 擴大採用即時分子檢測來快速識別呼吸道病原體
  • 將人工智慧驅動的演算法整合到肺功能測試中以實現早期疾病檢測
  • 使用可連接智慧型手機的家用肺量計設備監測慢性阻塞性肺病激增
  • 增加對可攜式氣溶膠分析平台的投資，用於即時監測空氣傳播的病原體
  • 多重即時PCR檢測板的出現，可同時檢測多種呼吸道病毒
  • 擴展基於 CRISPR 的檢測方法，以便在臨床環境中靈敏地檢測新興呼吸道病原體
  • 呼吸組學技術的發展，用於呼吸系統疾病診斷中的非侵入性生物標記分析

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

8. 呼吸診斷市場（依診斷檢驗）

  • 血液檢查
    • 動脈血氣
    • 全血球計數
  • 影像檢查
    • 胸部X光檢查
    • 電腦斷層掃描
    • 核磁共振掃描
  • 肺功能檢查
    • 擴散容量測試
    • 肺容量測試
    • 肺量計
  • 分子檢測
    • 抗原檢測
    • 生物標記檢測
    • PCR檢測
  • 脈搏血氧計
  • 痰液檢查

第9章呼吸診斷市場（依患者人口統計）

  • 成人
  • 老年人
  • 孩子們

第 10 章呼吸診斷市場（按產品提供）

  • 裝置
    • 容積描記器
    • 診斷影像系統
    • 氣體分析儀
    • 肺量計系統
  • 服務
  • 軟體
    • 數據分析軟體
    • 影像分析軟體
    • 肺功能測試（PFT）軟體

第 11 章呼吸診斷市場（依最終用戶）

  • 學術機構
  • 診斷實驗室
  • 醫院和診所
  • 研究所

12.美洲呼吸診斷市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

13. 歐洲、中東和非洲呼吸診斷市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

14.亞太呼吸診斷市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第15章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Becton, Dickinson, and Company
    • Abbott Laboratories
    • Adaltis Srl
    • Altona Diagnostics GmbH
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • Bioneer Corporation
    • CerTest Biotec SL
    • Daan Gene Co., Ltd.
    • Diatech Pharmacogenetics srl
    • Dragerwerk AG & Co. KGaA
    • F. Hoffmann-La Roche Ltd.
    • GE HealthCare Technologies, Inc.
    • Hologic, Inc.
    • Johnson & Johnson Services, Inc.
    • Koninklijke Philips NV
    • Masimo Corporation
    • Medtronic PLC
    • Merck KGaA
    • ProAxsis by NetScientific PLC
    • Quest Diagnostics Incorporated
    • Quidel Corporation
    • Sansure Biotech Inc.
    • SDI Diagnostics, Inc.
    • Seegene Inc.
    • Siemens Healthineers AG
    • ResMed Corp.
    • Thermo Fisher Scientific Inc.
    • Vitalograph Ltd.
    • ZeptoMetrix LLC

第16章 研究人工智慧

第17章 研究統計

第18章 研究聯絡人

第19章 研究報導

第20章 附錄

Product Code: MRR-894699F5EBCB

The Respiratory Diagnostics Market was valued at USD 6.66 billion in 2024 and is projected to grow to USD 7.26 billion in 2025, with a CAGR of 8.66%, reaching USD 10.97 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 6.66 billion
Estimated Year [2025] USD 7.26 billion
Forecast Year [2030] USD 10.97 billion
CAGR (%) 8.66%

Navigating the Complex Respiratory Diagnostics Environment with Emerging Technologies and Regulatory Dynamics Steering Future Developments

The respiratory diagnostics landscape has experienced an unprecedented surge in both technological innovation and global health urgency. Driven by rising prevalence of chronic respiratory conditions and heightened patient awareness, the industry has entered a phase of dynamic evolution. Advanced analytical tools, point-of-care devices, and digital health platforms are converging to create more precise, rapid, and accessible diagnostic pathways. Moreover, shifting regulatory requirements across major markets have introduced new compliance challenges, necessitating adaptive strategies across the entire value chain.

Amid these complexities, this report provides a comprehensive exploration of the key market forces influencing respiratory diagnostics. It paints a clear picture of how technological breakthroughs are intersecting with demographic trends, healthcare protocols, and reimbursement frameworks. By establishing a foundational understanding of current drivers and barriers, this introduction sets the stage for deeper analysis. As you navigate this landscape, the insights presented here will illuminate strategic opportunities and potential pitfalls, empowering decision-makers to chart a forward-looking course in an increasingly competitive environment.

Exploring Pivotal Technological and Operational Transformations Reshaping the Respiratory Diagnostics Ecosystem in a Post-Pandemic Era

Over the past several years, respiratory diagnostics has been transformed by breakthroughs in digital health and the integration of artificial intelligence. Machine learning algorithms now support high-resolution imaging interpretation, enabling clinicians to detect early-stage anomalies with greater accuracy. Meanwhile, cloud-based analytics platforms facilitate the seamless aggregation of patient data across multiple touchpoints, offering more holistic insights into disease progression. These shifts have not only accelerated diagnostic timelines but also lowered overall operational costs.

In addition to technological advances, the industry is experiencing a paradigm shift toward decentralized care models. Point-of-care testing solutions are proliferating beyond hospital settings into community clinics and home-based environments. This expansion is accompanied by growing emphasis on patient empowerment and remote monitoring, which together foster proactive disease management. Consequently, manufacturers and service providers are increasingly focusing on modular, portable solutions that can adapt to a range of clinical workflows. These transformative forces are redefining traditional value chains, encouraging stakeholders to adopt agile development and collaborative partnerships.

Analyzing the Compound Effects of United States Tariff Implementations in 2025 on Supply Chains, Cost Structures, and Market Adaptations

The United States' tariff adjustments implemented in 2025 have exerted a considerable influence on the global respiratory diagnostics supply chain. Imported components faced elevated duties, prompting device manufacturers to reassess sourcing strategies and partner networks. As a result, production costs experienced a noticeable escalation, particularly for high-precision imaging systems and advanced molecular assay kits. In response, several key players pursued nearshoring initiatives, relocating assembly lines closer to end markets to mitigate duty impacts and ensure delivery continuity.

Beyond immediate cost implications, these tariff measures have catalyzed broader strategic realignments. Organizations have intensified supplier diversification efforts to reduce dependency on any single geographic region. Concurrently, there has been a surge in investment toward local manufacturing capabilities and quality control infrastructure. These adjustments have not only buffered the effects of trade policy volatility but also fostered resilience in the face of future disruptions. Overall, the cumulative impact of the 2025 tariff regime underscores the critical importance of supply chain agility and strategic foresight in managing regulatory headwinds.

Unpacking Diverse Market Segmentation Perspectives Highlighting Test Modalities, Demographic Cohorts, Solution Offerings, and End-User Applications

An in-depth look at diagnostic test modalities reveals that blood-based assessments such as arterial blood gas analysis and complete blood count remain foundational tools for evaluating respiratory function and identifying systemic inflammation. Imaging platforms spanning chest X-rays, CT scans, and MRI scans continue to serve as critical modalities for visualizing structural abnormalities. At the same time, lung function tests like spirometry, diffusion capacity measurements, and lung volume assessments are essential for tracking disease progression and guiding therapeutic interventions. Advanced molecular tests including PCR assays, antigen detection, and biomarker profiling further enrich diagnostic accuracy, while pulse oximetry and sputum analysis protocols facilitate ongoing monitoring in both clinical and at-home settings.

Patient demographic segmentation highlights how adult populations drive baseline demand, while geriatric cohorts increasingly rely on complex diagnostic combinations to manage age-related pulmonary disorders. Pediatric segments, by contrast, often prioritize minimally invasive and radiation-free techniques, aligning with safety considerations. Examining market offerings underscores that equipment portfolios-ranging from spirometry systems and gas analyzers to body plethysmographs and diagnostic imaging units-form the backbone of capital investment. Complementary services such as calibration, maintenance, and clinical support services reinforce equipment performance. Meanwhile, specialized software solutions offering data analytics, imaging processing, and pulmonary function testing management are gaining traction as indispensable components of integrated diagnostic ecosystems. Finally, end-user analysis indicates that hospitals and clinics represent the primary consumption hubs, followed by diagnostic laboratories, research institutes, and academic institutions, each driving tailored requirements for throughput, data integration, and reporting capabilities.

Dissecting Regional Growth Drivers and Market Nuances across the Americas, Europe Middle East Africa, and Asia-Pacific Respiratory Diagnostics Arenas

Regional dynamics in respiratory diagnostics exhibit clear differentiation driven by healthcare infrastructure maturity, regulatory environments, and economic factors. In the Americas, advanced clinical networks and expansive reimbursement regimes catalyze rapid adoption of high-end imaging systems and molecular diagnostics. Meanwhile, research funding and public health initiatives further strengthen market momentum. The Europe, Middle East, and Africa region presents a multifaceted environment where Western European markets emphasize technological sophistication and stringent regulatory compliance, while Middle Eastern and African nations pursue capacity building through public-private partnerships and targeted disease screening programs.

Asia-Pacific stands out for its diverse market trajectories, as developed economies such as Japan and Australia leverage digital health integration, whereas emerging markets prioritize cost-effective, portable testing solutions to broaden diagnostic reach. Government-led health campaigns and expanding private sector participation are key drivers of growth across the region. Collectively, these regional nuances underscore the importance of tailored go-to-market strategies that align with local regulatory frameworks, reimbursement landscapes, and healthcare delivery models.

Illuminating Competitive Dynamics and Innovation Strategies Employed by Leading Enterprises Shaping the Respiratory Diagnostics Sector's Evolution

Leading organizations within the respiratory diagnostics sphere have converged on a few critical strategies to maintain competitive advantage. Strategic partnerships between imaging system manufacturers and software analytics providers have emerged, combining hardware innovations with advanced data interpretation algorithms. This collaborative approach has accelerated the roll-out of integrated diagnostic platforms capable of seamless data exchange and remote accessibility. Simultaneously, acquisitions of niche molecular assay developers by large diagnostic conglomerates have bolstered assay portfolios, enhancing the scope of disease detection and personalized treatment planning.

New entrants differentiate through agile business models, offering subscription-based or as-a-service equipment deployment to reduce capital expenditure burdens on healthcare providers. Additionally, several companies have established centers of excellence in emerging markets to support localized R&D and regulatory approvals. The focus on continuous product lifecycle management, guided by post-market surveillance and real-world evidence collection, further demonstrates how top-tier players are leveraging data-driven feedback loops to refine their offerings. These collective competitive maneuvers illustrate a sector characterized by rapid consolidation, innovation-driven partnerships, and evolving commercial frameworks.

Delivering Insightful Strategic Imperatives to Enhance Innovation, Collaboration, and Operational Resilience within the Respiratory Diagnostics Industry

To capitalize on market opportunities, industry leaders should prioritize investment in interoperable digital platforms that integrate diverse diagnostic data streams, enabling real-time decision support. By fostering collaborative ecosystems with software developers and academic institutions, organizations can co-create advanced analytics solutions that anticipate evolving clinical needs. Concurrently, diversifying supply chains through dual sourcing and nearshoring can mitigate tariff-related disruptions and ensure consistent device availability.

Moreover, pursuing modular product designs will allow rapid customization for distinct end-user environments, from high-throughput hospital labs to decentralized community clinics. Engaging proactively with regulatory authorities and participating in standards-development consortia will streamline approval pathways and set benchmarks for quality and safety. Finally, embedding sustainability principles into manufacturing and packaging processes will not only address environmental concerns but also resonate with increasingly value-driven procurement practices. Taken together, these recommendations form a cohesive blueprint for sustaining growth and maintaining competitive differentiation within the respiratory diagnostics landscape.

Elucidating a Rigorous Multi-Phased Research Framework Integrating Primary Validation and Secondary Analysis for Robust Respiratory Diagnostics Intelligence

This research employs a meticulous multi-phased approach to ensure the highest level of accuracy and reliability. Primary data collection involved comprehensive interviews with key opinion leaders, including pulmonologists, laboratory directors, and regulatory specialists, to capture firsthand insights on emerging trends, clinical workflows, and procurement drivers. These qualitative findings were supplemented by a detailed review of public filings, technical whitepapers, and regulatory databases, providing a robust secondary data foundation.

Quantitative analysis was conducted through data triangulation methodologies, cross-referencing supply chain metrics, healthcare expenditure reports, and product launch timelines. The resulting data sets underwent rigorous validation, employing statistical techniques to identify outliers and verify consistency. Additionally, a proprietary assessment framework evaluated each technology's maturity, adoption potential, and competitive positioning. This layered research protocol ensures that conclusions are grounded in empirical evidence and reflect the latest evolutions shaping respiratory diagnostics.

Synthesizing Key Discoveries and Future Trajectories to Guide Strategic Progression in Respiratory Diagnostic Endeavors and Sector Perspectives

Drawing together the critical insights outlined throughout this summary, it becomes clear that respiratory diagnostics is entering an era defined by digital integration, strategic supply chain realignment, and collaborative innovation. The interplay between advanced imaging platforms and molecular assays is driving a more nuanced understanding of respiratory pathologies. Simultaneously, regulatory reforms and tariff policies underscore the importance of operational agility and proactive stakeholder engagement.

Looking ahead, organizations that embrace modular, data-driven solutions and cultivate diverse partnerships will be best positioned to navigate market complexities. By applying the strategic imperatives detailed here, decision-makers can capitalize on emerging opportunities, mitigate potential risks, and deliver enhanced patient outcomes. Ultimately, this report offers a roadmap for achieving sustained growth and leadership in a dynamic respiratory diagnostics environment, supporting stakeholders in making informed, future-focused choices.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Increasing adoption of point-of-care molecular testing for rapid identification of respiratory pathogens
  • 5.2. Integration of AI-driven algorithms in pulmonary function testing for early disease detection
  • 5.3. Surge in utilization of home-based spirometry devices with smartphone connectivity for chronic obstructive pulmonary disease monitoring
  • 5.4. Rising investments in portable aerosol analysis platforms for real-time monitoring of airborne pathogens
  • 5.5. Emergence of multiplex real-time PCR panels enabling simultaneous detection of multiple respiratory viruses
  • 5.6. Expansion of CRISPR-based assays for highly sensitive detection of emerging respiratory pathogens in clinical settings
  • 5.7. Development of breathomics technology for non-invasive biomarker profiling in respiratory disease diagnosis

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Respiratory Diagnostics Market, by Diagnostic Tests

  • 8.1. Introduction
  • 8.2. Blood Tests
    • 8.2.1. Arterial Blood Gases
    • 8.2.2. Complete Blood Count
  • 8.3. Imaging Tests
    • 8.3.1. Chest X-Rays
    • 8.3.2. CT Scans
    • 8.3.3. MRI Scans
  • 8.4. Lung Function Tests
    • 8.4.1. Diffusion Capacity Tests
    • 8.4.2. Lung Volume Tests
    • 8.4.3. Spirometry
  • 8.5. Molecular Tests
    • 8.5.1. Antigen Tests
    • 8.5.2. Biomarker Tests
    • 8.5.3. PCR Tests
  • 8.6. Pulse Oximetry
  • 8.7. Sputum Tests

9. Respiratory Diagnostics Market, by Patient Demographics

  • 9.1. Introduction
  • 9.2. Adult
  • 9.3. Geriatric
  • 9.4. Pediatric

10. Respiratory Diagnostics Market, by Offerings

  • 10.1. Introduction
  • 10.2. Equipment
    • 10.2.1. Body Plethysmographs
    • 10.2.2. Diagnostic Imaging Systems
    • 10.2.3. Gas Analysis Devices
    • 10.2.4. Spirometry Systems
  • 10.3. Services
  • 10.4. Software
    • 10.4.1. Data Analytics Software
    • 10.4.2. Imaging Analysis Software
    • 10.4.3. Pulmonary Function Testing (PFT) Software

11. Respiratory Diagnostics Market, by End Users

  • 11.1. Introduction
  • 11.2. Academic Institutions
  • 11.3. Diagnostic Laboratories
  • 11.4. Hospitals & Clinics
  • 11.5. Research Institutes

12. Americas Respiratory Diagnostics Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Respiratory Diagnostics Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Respiratory Diagnostics Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Becton, Dickinson, and Company
    • 15.3.2. Abbott Laboratories
    • 15.3.3. Adaltis S.r.l.
    • 15.3.4. Altona Diagnostics GmbH
    • 15.3.5. Bio-Rad Laboratories, Inc.
    • 15.3.6. bioMerieux S.A.
    • 15.3.7. Bioneer Corporation
    • 15.3.8. CerTest Biotec S.L.
    • 15.3.9. Daan Gene Co., Ltd.
    • 15.3.10. Diatech Pharmacogenetics srl
    • 15.3.11. Dragerwerk AG & Co. KGaA
    • 15.3.12. F. Hoffmann-La Roche Ltd.
    • 15.3.13. GE HealthCare Technologies, Inc.
    • 15.3.14. Hologic, Inc.
    • 15.3.15. Johnson & Johnson Services, Inc.
    • 15.3.16. Koninklijke Philips N.V.
    • 15.3.17. Masimo Corporation
    • 15.3.18. Medtronic PLC
    • 15.3.19. Merck KGaA
    • 15.3.20. ProAxsis by NetScientific PLC
    • 15.3.21. Quest Diagnostics Incorporated
    • 15.3.22. Quidel Corporation
    • 15.3.23. Sansure Biotech Inc.
    • 15.3.24. SDI Diagnostics, Inc.
    • 15.3.25. Seegene Inc.
    • 15.3.26. Siemens Healthineers AG
    • 15.3.27. ResMed Corp.
    • 15.3.28. Thermo Fisher Scientific Inc.
    • 15.3.29. Vitalograph Ltd.
    • 15.3.30. ZeptoMetrix LLC

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. RESPIRATORY DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. RESPIRATORY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. RESPIRATORY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. RESPIRATORY DIAGNOSTICS MARKET: RESEARCHAI
  • FIGURE 24. RESPIRATORY DIAGNOSTICS MARKET: RESEARCHSTATISTICS
  • FIGURE 25. RESPIRATORY DIAGNOSTICS MARKET: RESEARCHCONTACTS
  • FIGURE 26. RESPIRATORY DIAGNOSTICS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. RESPIRATORY DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ARTERIAL BLOOD GASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ARTERIAL BLOOD GASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHEST X-RAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHEST X-RAYS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CT SCANS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CT SCANS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MRI SCANS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MRI SCANS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIFFUSION CAPACITY TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIFFUSION CAPACITY TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG VOLUME TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG VOLUME TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ANTIGEN TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ANTIGEN TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETRY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPUTUM TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPUTUM TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BODY PLETHYSMOGRAPHS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BODY PLETHYSMOGRAPHS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GAS ANALYSIS DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GAS ANALYSIS DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DATA ANALYTICS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DATA ANALYTICS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING ANALYSIS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTING (PFT) SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTING (PFT) SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 109. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 113. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 115. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 117. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 131. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 132. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 133. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 134. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 135. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 136. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 137. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 138. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 139. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 140. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 141. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 142. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 143. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 144. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 145. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 146. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 147. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 148. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 149. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 150. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 151. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 152. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 153. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 154. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 155. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 156. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 157. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 158. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 159. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 160. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 161. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 162. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 163. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 164. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 165. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 166. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 167. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 168. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 169. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 170. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 171. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 172. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 173. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 174. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 175. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 176. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 177. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 178. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 179. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 180. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 181. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 182. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 183. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 184. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 185. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 186. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 187. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 188. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 189. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 190. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 191. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 192. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 193. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 194. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 195. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 196. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 197. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 198. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 199. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 200. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 201. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 202. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 203. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 204. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 205. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 206. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 207. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 208. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 209. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 210. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 211. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 212. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 213. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 214. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 215. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 216. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 217. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 218. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 219. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 220. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 244. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 245. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 246. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 247. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 248. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 249. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 250. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 251. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 252. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 253. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 254. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 255. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 256. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 257. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 259. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 261. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 263. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 264. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 265. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 266. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 267. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 268. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 269. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 270. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 271. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 272. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 273. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 274. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 275. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 276. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 277. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 278. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 279. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 280. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 281. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 282. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 283. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 284. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 285. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 286. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 287. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 288. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 289. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 290. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 291. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 292. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 293. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 294. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 295. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 296. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 297. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 298. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 299. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 300. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 301. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 302. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 303. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 304. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 305. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 306. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 307. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 308. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 309. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 310. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 311. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 312. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 313. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 314. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 315. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 316. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 317. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 318. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 319. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 320. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 321. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 322. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE,